Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04051294 · ClinicalTrials.gov registry record · NA

The Effect of Kombucha on Blood Sugar Levels in Humans

A NA study of Blood Sugar; High and Glucose, sponsored by University of Missouri-Columbia.

Completed
Registry status
NA
Development phase
33
Enrollment target
1
Study location

NCT04051294 is a NA study of Blood Sugar; High and Glucose that has completed, run by University of Missouri-Columbia. The registered enrollment target is 33 participants, roughly in line with the 32-participant average among 5 other Blood Sugar; High trials with a reported enrollment target. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04051294, a NA study of Blood Sugar; High and Glucose, has completed, sponsored by University of Missouri-Columbia.

COMPLETED
Registry status
NA
Development phase
33 participants
Enrollment target
1
Study location

Study Summary

As a phase 0 clinical trial, we will learn how kombucha influences glucose metabolism in humans.

Interventions

  • DIETARY_SUPPLEMENT Commercial kombucha tea
  • DIETARY_SUPPLEMENT Brewed kombucha tea
  • OTHER Control: Tea
  • OTHER Control: Water

Study Locations (1)

Missouri

  • University of Missouri - Columbia

Trial Details

FieldValue
Enrollment Target 33 participants
Start Date 2019-01-03
Est. Completion 2022-09-30
Phase NA

Sponsor

University of Missouri-Columbia

291 total trials

What the Registry Record Tells You About NCT04051294

The ClinicalTrials.gov registry entry for NCT04051294 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 32-participant average among 5 other Blood Sugar; High trials with a reported enrollment target. The listed sponsor is University of Missouri-Columbia, which has 291 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Blood Sugar; High appearing as the primary indexed condition, and to 4 interventions - of which Commercial kombucha tea is the first listed.

NCT04051294 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.

Frequently Asked Questions

What is clinical trial NCT04051294 about?

NCT04051294 is a clinical study titled "The Effect of Kombucha on Blood Sugar Levels in Humans". As a phase 0 clinical trial, we will learn how kombucha influences glucose metabolism in humans.

What is the current status of trial NCT04051294?

This trial is currently completed. It is a NA study. The enrollment target is 33 participants. The study started on 2019-01-03. Estimated completion is 2022-09-30.

What conditions does trial NCT04051294 study?

This clinical trial studies the following conditions: Blood Sugar; High, Glucose, Glucose Metabolism Disorders (Including Diabetes Mellitus).

What interventions are being tested in trial NCT04051294?

The interventions under investigation include: Commercial kombucha tea (DIETARY_SUPPLEMENT), Brewed kombucha tea (DIETARY_SUPPLEMENT), Control: Tea (OTHER), Control: Water (OTHER).

Who is sponsoring clinical trial NCT04051294?

This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04051294 being conducted?

This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Blood Sugar; High

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.